HOME >> BIOLOGY >> NEWS
Groundbreaking study by Field Museum scientists explains mane variation in lions

CHICAGO--An article appearing in the current issue of the Journal of Zoology sheds light on several longstanding misconceptions regarding the controversial topic of mane variability among wild lions. This comprehensive scientific assessment of mane variation--including "manelessness"--is a first and took nearly seven years to complete.

According to the overall findings of the study, wild lions generally develop manes in accordance with local climate regimes. In Equatorial east Africa, climate is determined by elevation. Thus lions with the most profuse manes occur at the upper limit of their altitudinal range, while similar aged males in the lowest and warmest environments like Tsavo typically carry only modest or scanty manes.

However, the authors also found, paradoxically, that the majority of lions in regions like the greater Tsavo ecosystem (which is famed for its "maneless" lions), did appear to acquire respectable manes, eventually, contrary to most recent popular and scientific accounts of the lions from that region.

"We knew about the climate/elevation correlation since we were the first to publish those preliminary results in GEO 2001, but this new development really threw us for a loop," says Tom Gnoske, of the Field Museum's Zoology Department and senior author of the paper. "However once we analyzed all of the statistical data we found a very strong correlation linking increased age and continued mane development, a significant variable ignored by all previous authors."

Statistical data from this study demonstrates that the onset of mane development in lions living below an altitude of 800 meters on or near the equator is delayed, and that the "rate" or speed at which a mane develops in lions from those regions is slower on average than that of the more familiar lions living in the cooler, higher altitudes of the greater Serengeti ecosystem and elevated plains extending northward, suc
'"/>

Contact: Greg Borzo
gborzo@fieldmuseum.org
312-665-7106
Field Museum
25-Sep-2006


Page: 1 2 3 4

Related biology news :

1. Kaiser Permanente Unveils Groundbreaking Genetic Research Program
2. Kaiser Permanente Unveils Groundbreaking Genetic Research Program
3. Groundbreaking research highlights myriad health benefits of flavanol-rich cocoa
4. Groundbreaking study shows adult stem cells have same ability to self-renew as embryonic
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. Clones on task serve greater good, evolutionary study shows
7. Pollution causes 40 percent of deaths worldwide, study finds
8. A study by the MUHC and McGill University opens a new door to understanding cancer
9. New study suggests Concord grape juice may provide protection against breast cancer
10. Preclinical study links gene to brain aneurysm formation
11. In limiting life span, study finds booming bacteria innocent

Post Your Comments:
(Date:5/11/2015)... -- Through a well-rounded UAS delegation representing private industry, government, and ... at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people from ... UAS ecosystem. "Our message is clear and ... Rich Knoll . "If you want to fly UAS, ...
(Date:5/7/2015)... 7, 2015 Fingerprint Cards ... and FPC1035, FPC,s smallest touch fingerprint sensors to ... considered for integration on the backside of the ... increased possibilities to integrate touch fingerprint sensors in ... improves possibilities for module manufacturers to customize the ...
(Date:4/27/2015)... Conn. , Apr. 27, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... commence shipping to pre-order customers the first week of ... through the month of May. ... a significant milestone for the company as Wocket® enters ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... Ontario (PRWEB) May 21, 2015 ... into an exclusive North American distribution agreement with ... testing system. , With more than 160 years ... products and services for laboratory and production facilities, ... operational excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: